Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ge [Genetics]. Found 32 abstracts

no pagination
Gudima S, Meier A, Dunbrack R, Taylor J, Bruss V. Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus. Journal of Virology. 2007 Apr;81(8):4343-7.
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium.[see comment]. Cell. 2007 Jun 29;129(7):1351-63.
Chen X, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Review of Anticancer Therapy. 2006 Feb;6(2):187-96.
Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN, National Comprehensive Cancer N. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network. 2006 Feb;4(2):156-76.
Murphy ME, Cassimeris L. A novel cancer therapy approach targeting microtubule function.[comment]. Cancer Biology & Therapy. 2006 Dec;5(12):1721-3.
Wang G, Kossenkov AV, Ochs MF. LS-NMF: a modified non-negative matrix factorization algorithm utilizing uncertainty estimates. BMC Bioinformatics. 2006 Jan;7:175.
Adams PD. Application of magnetic beads to purify cells transiently transfected with plasmids encoding short hairpin RNAs. Methods in Molecular Biology. 2005 Jan;296:189-96.
Bookman MA. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic. International Journal of Gynecological Cancer. 2005 May;15 Suppl 1:12-7.
Daly MB, Stearman B, Masny A, Sein E, Mazzoni S. How to establish a high-risk cancer genetics clinic: limitations and successes. Current oncology reports. 2005 Nov;7(6):469-74.
Gate L, Majumdar RS, Lunk A, Tew KD. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. International journal of cancer. 2005 Jan;113(1):29-35.
Hayashi J, Stoyanova R, Seeger C. The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology. 2005 May 10;335(2):264-75.
Henske EP. Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatric Nephrology. 2005 Jul;20(7):854-7.
Knudson A. Retinoblastoma: teacher of cancer biology and medicine.[comment]. PLoS Medicine / Public Library of Science. 2005 Oct;2(10):e349.
Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Research. 2005 May 15;65(10):4162-71.
Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. The Prostate. 2005 Dec;65(4):331-40.
Tarn C, Godwin AK. Molecular research directions in the management of gastrointestinal stromal tumors. Current treatment options in oncology. 2005 Nov;6(6):473-86.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Balogh GA, Russo IH, Russo J. Truncation of the mismatch repair protein PMS2 during the neoplastic transformation of human breast epithelial cells in vitro. International Journal of Oncology. 2004 Aug;25(2):381-7.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
Daniel R, Greger JG, Katz RA, Taganov KD, Wu X, Kappes JC, Skalka AM. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway. Journal of Virology. 2004 Aug;78(16):8573-81.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ge [Genetics]

ge [Genetics] me [Metabolism] Non-US Gov't Research Support Female ph [Physiology] NIH Research Support-Extramural Mutation Male Breast Neoplasms Cell Line th [Therapy] bi [Biosynthesis] Transfection ai [Antagonists & Inhibitors] mt [Methods] Neoplastic Gene Expression Regulation Genetic Predisposition to Disease Risk Factors Messenger RNA ch [Chemistry] Ovarian Neoplasms pd [Pharmacology] pa [Pathology] Messenger) 0 (RNA US Gov't Support-PHS Oligonucleotide Array Sequence Analysis 0 (Isoenzymes) Comparative Study Mice Small Interfering) 0 (RNA Enzymologic Gene Expression Regulation tu [Therapeutic Use] Tumor Cell Line Genetic Screening Prognosis US Gov't Support-Non-PHS rt [Radiotherapy] dt [Drug Therapy] Small Interfering RNA Genetic Counseling Protein-Serine-Threonine Kinases Signal Transduction Proto-Oncogene Proteins c-bcl-2 Gene Expression EC 2-7-1-37 (Protein-Serine-Threonine Kinases) 0 (DNA-Binding Proteins) de [Drug Effects] en [Enzymology] DNA-Binding Proteins vi [Virology] BRCA1 Genes Apoptosis US Gov't Research Support-Non-PHS Cultured Cells Isoenzymes Phosphorylation Neoplasms 0 (Proto-Oncogene Proteins c-bcl-2) Phenotype 0 (Viral Envelope Proteins) EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) 0 (Bax protein) EC 2-7-1-37 (Protein Kinase C) Biological) 0 (Tumor Markers Prostaglandin-Endoperoxide Synthase BRCA1 Protein td [Trends] SCID Mice Alleles Quality Control Furin Proto-Oncogene Proteins Antisense) 0 (DNA py [Pathogenicity] Flow Cytometry human) EC 3-6-1 (PMS2 protein EC 2-5-1-18 (glutathione S-transferase pi) Biological Markers Research Design Signal Transducing Adaptor Proteins 152459-95-5 (imatinib) Protein Precursors an [Analysis] Enzyme Activation 0 (Biological Markers) human) 0 (NEDD9 protein 0 (Retinoblastoma Protein) CD19 Antigens im [Immunology] Adult Protein Kinase C human) 0 (PLAGL1 protein Protein p53 Antisense DNA sn [Statistics & Age Factors 0 (Stathmin) Gene Expression Profiling EC 1-14-99 (cyclooxygenase 2) 0 (Peptide Fragments) Middle Aged 0 (Cyclin-Dependent Kinase Inhibitor p21) Rats Genotype df [Deficiency] RNA Neoplasm) 0 (DNA Retinoblastoma Virus Internalization Fibroblasts EC 2-7-1-37 (DNA-activated protein kinase) Hepatitis Delta Virus aa [Analogs & Derivatives] Molecular Models 63231-63-0 (rna) Peptide Fragments Inbred F344 Rats DNA Repair Local Neoplasm Recurrence EC 2-7-1 (protein kinase C alpha) HIV-1 ep [Epidemiology] Carcinoma 0 (XRCC4 protein) cy [Cytology] Experimental Neoplasms Aging Hepatocytes 0 (Protein Precursors) Physician's Role Piperazines 0 (Genetic Vectors) Pediatrics Viral Envelope Proteins CD20 Antigens DNA Repair Enzymes Incidence Dinoprostone Protein-Tyrosine Kinase 951-77-9 (Deoxycytidine) Genetic Vectors EC 3-6-1-3 (Adenosinetriphosphatase) Tuberous Sclerosis Prostatic Neoplasms US Gov't Research Support-PHS Cyclin-Dependent Kinase Inhibitor p21 et [Etiology] Stathmin Viral DNA Phosphoproteins
Last updated on Saturday, July 04, 2020